(Q72564074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Cerebrospinal fluid [Met5]enkephalin level in schizophrenics during treatment with naloxone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Cerebrospinal fluid [Met5] enkephalin level in schizophrenics during treatment with naloxone (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

12 August 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

12 August 2023

author name string

C. W. Lo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6138259

12 August 2023

H. L. Wen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6138259

12 August 2023

W. K. Ho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6138259

12 August 2023

language of work or name

English

0 references

publication date

1 August 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

19 August 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6138259

full work available at URL

12 August 2023

https://api.elsevier.com/content/article/PII:0014299983901103?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

https://api.elsevier.com/content/article/PII:0014299983901103?httpAccept=text/plain

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

European Journal of Pharmacology

12 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

77-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

27 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Does dopamine have a role in schizophrenia?

12 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Intravenous Naloxone Administration in Schizophrenia and Affective Illness

12 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Morphine, enkephalin and the substantia gelatinosa

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Lack of effect on naloxone on schizophrenic symptoms

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Endorphins in human cerebrospinal fluid

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Increased CSF levels of endorphines in chronic psychosis

12 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Naloxone in chronic schizophrenia

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Action of naloxone and naltrexone in different types of psychoses

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Effects of Naloxone on Schizophrenia: Reduction in Hallucinations in a Subpopulation of Subjects

12 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

Effects of endorphins on single myenteric neurons

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(83)90110-3

12 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6138259%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference